Silexion Therapeutics Ltd. (SLXN) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q1'21 |
|---|
| Total Current Assets | 4.07M | 6.64M | 11.05M | 5.24M | 7.72M | 2.25M | 3.05M | 2.31M | 3.34M | 4.98M | 5.67M | 27.48M | 113.38K | 8.84M | 327.44K | 224.16K | 466.6K | 407.8K | 634.3K |
| Cash & Short-Term Investments | 2.41M | 5.99M | 9.24M | 3.47M | 6.15M | 1.19M | 1.97M | 1.7M | 2.78M | 4.59M | 5.64M | 27.44M | 71.5K | 8.26M | 202.33K | 17.8K | 179K | 38.94K | 346.69K |
| Cash Only | 2.41M | 5.99M | 9.24M | 3.47M | 6.15M | 1.19M | 1.97M | 1.7M | 2.78M | 4.59M | 58.24K | 34.53K | 71.5K | 8.26M | 202.33K | 17.8K | 179K | 38.94K | 346.69K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.58M | 27.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 123K | 76K | 73K | 88K | 92K | 97K | 130K | 91K | 93K | 49K | 0 | 0 | 0 | 67K | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 537K | 578K | 559K | 560K | 586K | 613K | 40K | 210K | 246K | 277K | 0 | 0 | 26.85M | 494K | 115.7M | 115.18M | 115.02M | 115.01M | 115.33M |
| Property, Plant & Equipment | 403K | 437K | 468K | 502K | 534K | 560K | 35K | 180K | 216K | 247K | 0 | 0 | 0 | 464K | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 58K | 57K | 0 | 53K | 47K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26.85M | 0 | 115.7M | 115.18M | 115.02M | 115.01M | 115M |
| Other Non-Current Assets | 76K | 84K | 91K | 5K | 5K | 53K | 5K | 30K | 30K | 30K | 0 | 0 | -1 | 30K | -1 | 0 | -1 | 0 | 325K |
| Total Assets | 4.6M | 7.21M | 11.61M | 5.8M | 8.31M | 2.86M | 3.09M | 2.52M | 3.58M | 5.26M | 5.67M | 27.48M | 26.96M | 9.33M | 116.03M | 115.4M | 115.48M | 115.41M | 115.96M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -44.61% | 152.01% | 276.22% | 129.58% | 131.74% | -45.53% | -45.56% | -90.81% | -86.7% | -43.68% | -95.11% | -76.19% | -76.65% | -91.91% | - | - | -0.41% | - | - |
| Total Current Liabilities | 4.06M | 2.76M | 2.79M | 2.15M | 2.4M | 3.52M | 3.58M | 2.36M | 1.94M | 2.2M | 2.53M | 2.24M | 1.88M | 1.61M | 1.01M | 672.16K | 757.62K | 348.58K | 48.8K |
| Accounts Payable | 912K | 787K | 0 | 692K | 722K | 929K | 799K | 281K | 244K | 319K | 0 | 0 | 0 | 240K | 0 | 0 | 0 | 0 | 0 |
| Days Payables Outstanding | 38.23K | - | - | - | - | - | 2.26K | 3.41K | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 185K | 182K | 174K | 0 | 0 | 1M | 229K | 0 | 0 | 0 | 2.49M | 2.11M | 1.6M | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.91M | 1.74M | 2.61M | 628K | 625K | 644K | 697K | 596K | 535K | 407K | 34.23K | 131.68K | 278.23K | 256K | 1.01M | 672.16K | 757.62K | 348.58K | 48.8K |
| Current Ratio | 1.00x | 2.41x | 3.97x | 2.44x | 3.22x | 0.64x | 0.85x | 0.98x | 1.72x | 2.27x | 2.25x | 12.26x | 0.06x | 5.49x | 0.32x | 0.33x | 0.62x | 1.17x | 13.00x |
| Quick Ratio | 1.00x | 2.41x | 3.97x | 2.44x | 3.22x | 0.64x | 0.85x | 0.98x | 1.72x | 2.27x | 2.25x | 12.26x | 0.06x | 5.49x | 0.32x | 0.33x | 0.62x | 1.17x | 13.00x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 251K | 1.85M | 1.85M | 3.53M | 3.33M | 3.33M | 4.08M | 15.06M | 15.09M | 15.12M | 9.4K | 24.34K | 24.76K | 14.8M | 19.25K | 28.8K | 65.15K | 160.34K | 348.46K |
| Long-Term Debt | 251K | 286K | 311K | 3.19M | 2.99M | 2.96M | 4.08M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 337K | 334K | 368K | 0 | 8K | 34K | 59K | 0 | 0 | 0 | 156K | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 1.57M | 1.54M | 0 | 0 | 0 | 0 | 15.06M | 15.06M | 15.06M | 9.4K | 24.34K | 24.76K | 14.65M | 19.25K | 28.8K | 65.15K | 160.34K | 348.46K |
| Total Liabilities | 4.31M | 4.61M | 4.64M | 5.68M | 5.72M | 6.85M | 7.67M | 17.43M | 17.03M | 17.31M | 2.53M | 2.27M | 1.91M | 16.41M | 1.03M | 700.97K | 822.77K | 508.92K | 397.26K |
| Total Debt | 436K | 468K | 485K | 3.7M | 3.48M | 4.49M | 4.31M | 116K | 144K | 171K | 2.49M | 2.11M | 1.6M | 271K | 0 | 0 | 0 | 0 | 0 |
| Net Debt | -1.98M | -5.52M | -8.76M | 232K | -2.67M | 3.3M | 2.34M | -1.58M | -2.64M | -4.42M | 2.43M | 2.08M | 1.53M | -7.99M | -202.33K | -17.8K | -179K | -38.94K | -346.69K |
| Debt / Equity | 1.50x | 0.18x | 0.07x | 30.82x | 1.35x | - | - | - | - | - | 0.79x | 0.08x | 0.06x | - | - | - | - | - | - |
| Debt / EBITDA | - | 0.02x | - | - | - | - | - | - | - | - | - | 12.95x | - | 0.55x | - | - | - | - | - |
| Net Debt / EBITDA | - | -0.29x | - | - | - | - | - | - | - | - | - | 12.74x | - | -16.16x | -0.69x | -0.42x | - | - | - |
| Interest Coverage | - | -734.33x | - | - | -191.78x | - | -227.04x | -742.50x | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 291K | 2.6M | 6.98M | 120K | 2.59M | -3.99M | -4.58M | -14.9M | -13.45M | -12.06M | 3.14M | 25.22M | 25.05M | -7.08M | 114.99M | 114.7M | 114.66M | 114.91M | 115.56M |
| Equity Growth % | -88.75% | 165.25% | 252.37% | 100.81% | 119.23% | 66.91% | -246% | -159.11% | -153.68% | -70.31% | -97.27% | -78.02% | -78.15% | -106.16% | - | - | -0.78% | - | - |
| Book Value per Share | 0.90 | 8.33 | 61.60 | 2.07 | 3.81 | -4.32 | -7.07 | -34.66 | -120.36 | -124.14 | 5.67 | 38.18 | 20.78 | -4.29 | 69.67 | 69.49 | 69.47 | 69.62 | 70.01 |
| Total Shareholders' Equity | 291K | 2.6M | 6.98M | 120K | 2.59M | -3.99M | -4.58M | -18.26M | -16.82M | -15.48M | 3.14M | 25.22M | 25.05M | -10.66M | 114.99M | 114.7M | 114.66M | 114.91M | 115.56M |
| Common Stock | 46K | 42K | 42K | 8K | 8K | 2K | 1K | 1K | 1K | 1K | 5.58M | 27.41M | 26.85M | 1K | 115.7M | 115.18M | 115M | 115M | 115M |
| Retained Earnings | -57.9M | -55.17M | -50.75M | -47.49M | -44.99M | -43.25M | -41.58M | -29.66M | -28.18M | -26.81M | -2.45M | -2.19M | -1.79M | -21.87M | -861.47K | -1.15M | -1.2M | -951.08K | -293.61K |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.35M | 3.37M | 3.42M | 0 | 0 | 0 | 3.59M | 0 | 0 | 0 | 0 | 0 |